当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析

科源制药

(301281)

  

流通市值:20.98亿  总市值:33.00亿
流通股本:6885.20万   总股本:1.08亿

科源制药(301281)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润0.60亿元,每股收益0.56元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益135960.35万元,未分配利润29005.37万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产155247.43万元,负债19287.07万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入463,716,804.91330,879,995.68237,142,859.74146,276,963.82
营业总成本415,074,066.11303,707,035.89211,807,312.62124,459,548.73
营业利润68,262,611.8745,779,440.8442,467,943.1224,428,408.78
利润总额65,708,514.6742,917,141.4640,737,829.9623,229,047.36
净利润60,271,862.2539,555,461.0936,027,184.1221,523,763.06
其他综合收益----
综合收益总额60,271,862.2539,555,461.0936,027,184.1221,523,763.06
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计690,734,868.56643,859,810.97710,579,541.14830,437,539.4
非流动资产合计861,739,402.58820,808,350.76758,032,179.21673,432,100.13
资产总计1,552,474,271.141,464,668,161.731,468,611,720.351,503,869,639.53
流动负债合计119,784,825.8599,136,243.47105,760,807.24125,506,446.68
非流动负债合计73,085,908.628,054,190.2629,357,642.4726,532,341.49
负债合计192,870,734.45127,190,433.73135,118,449.71152,038,788.17
归属于母公司股东权益合计1,358,795,634.771,336,620,591.671,332,572,437.031,350,854,873.84
股东权益合计1,359,603,536.691,337,477,7281,333,493,270.641,351,830,851.36
负债和股东权益合计1,552,474,271.141,464,668,161.731,468,611,720.351,503,869,639.53
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计367,204,068.33271,653,032.95190,116,391.6488,320,171.72
经营活动现金流出小计427,719,852.28247,782,116.39172,178,593.5789,961,054.86
经营活动产生的现金流量净额-60,515,783.9523,870,916.5617,937,798.07-1,640,883.14
投资活动现金流入小计970,622,262.23861,878,324.86506,296,462.373,527,905,218.34
投资活动现金流出小计1,158,200,062.05911,548,188.84640,172,339.933,318,488,995.97
投资活动产生的现金流量净额-187,577,799.82-49,669,863.98-133,875,877.56209,416,222.37
筹资活动现金流入小计47,631,955.61,000,0001,000,0001,000,000
筹资活动现金流出小计32,562,968.6632,487,820.7232,487,820.72-
筹资活动产生的现金流量净额15,068,986.94-31,487,820.72-31,487,820.721,000,000
汇率变动对现金及现金等价物的影响585,250.5381,826.89-30,335.11261,598.54
现金及现金等价物净增加额-232,439,346.33-56,904,941.25-147,456,235.32209,036,937.77
期末现金及现金等价物余额91,769,768.21267,304,173.29176,752,879.22568,547,454.88
TOP↑